The hematocrit testing market exhibits distinct regional characteristics reflecting variations in healthcare infrastructure development, economic conditions, regulatory environments, and disease prevalence patterns that create diverse commercial opportunities and challenges across global markets. North American markets demonstrate high testing adoption rates supported by advanced...